Pharmacological Properties of MM-706, a New Prostacyclin Derivative

Author： Ragazzi E. Chinellato A. Lille U. Lopp M. Doni M.G. Fassina G.

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.26, Iss.4, 1995-07, pp. : 703-709

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of Platelet Activation by MM-706, a Stable Carbacyclin Analog, in the Conscious Rat

By Meggiato C. Padoin E. Ragazzi E. Chinellato A. Doni M.G.

General Pharmacology, Vol. 28, Iss. 2, 1997-02 ,pp. : 251-255

Elsevier

Access to resources Recommend Favorite

Biochemical and pharmacological characterization of FK706, a novel elastase inhibitor

By Shinguh Y. Imai K. Yamazaki A. Inamura N. Shima I. Wakabayashi A. Higashi Y. Ono T.

European Journal of Pharmacology, Vol. 337, Iss. 1, 1997-10 ,pp. : 63-71

Elsevier

Access to resources Recommend Favorite

New Trends in Thromboxane and Prostacyclin Modulators

Current Medicinal Chemistry, Vol. 7, Iss. 6, 2000-06 ,pp. : 609-628

Bentham Science Publishers

Access to resources Recommend Favorite

New Developments on Thromboxane and Prostacyclin Modulators Part II: Prostacyclin Modulators

Current Medicinal Chemistry, Vol. 11, Iss. 10, 2004-05 ,pp. : 1243-1252

Bentham Science Publishers

Access to resources Recommend Favorite

The pharmacological profile of ML3000: A new pyrrolizine derivative inhibiting the enzymes cyclo-oxygenase and 5-lipoxygenase

By Tries S.

Inflammopharmacology, Vol. 9, Iss. 1-2, 2001-05 ,pp. : 113-124

VSP

Access to resources Recommend Favorite